CD34 and acute myeloid leukemia: Found in 77.9% of patients with AML [77], CD123 is expressed in CD34+CD38- AML cells [78], and its overexpression is associated with constitutive phosphorylation of STAT5, which accelerates cell proliferation and leads to a poor prognosis [79].